American Century Companies Inc. Lowers Stake in IDEXX Laboratories

Investment firm reduces holdings in veterinary diagnostics company by 17.3% in Q3

Published on Feb. 28, 2026

American Century Companies Inc. lowered its position in shares of IDEXX Laboratories, Inc. (NASDAQ:IDXX) by 17.3% in the third quarter, according to the company's recent 13F filing with the Securities & Exchange Commission. The fund owned 705,158 shares of the company's stock worth $450,518,000 at the end of the reporting period.

Why it matters

IDEXX Laboratories is a leading provider of diagnostic products and services for the animal health market. The company's stock has been a strong performer, and changes in institutional ownership can provide insights into investor sentiment and the stock's outlook.

The details

American Century Companies reduced its stake in IDEXX Laboratories by selling 148,003 shares during the third quarter. The investment firm now owns a 0.88% stake in the company, down from 1.05% previously. IDEXX Laboratories' stock has seen strong gains in recent years, driven by the company's growth in the veterinary diagnostics market.

  • American Century Companies filed its 13F report for the third quarter of 2026.

The players

American Century Companies Inc.

An investment management firm that provides a range of investment strategies and products to individual and institutional clients.

IDEXX Laboratories, Inc.

A global developer, manufacturer, and provider of diagnostic products and services primarily for the animal health, water testing, and food safety markets.

Got photos? Submit your photos here. ›

The takeaway

The reduction in American Century's stake in IDEXX Laboratories is a relatively small change in ownership, but it could signal a shift in investor sentiment or portfolio rebalancing. The veterinary diagnostics market remains a growth area, and IDEXX's strong performance has made it a closely watched stock among investors.